Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review

V Clifford, Y He, C Zufferey, T Connell, N Curtis - Tuberculosis, 2015 - Elsevier
Introduction The ability to monitor the response to therapy for tuberculosis (TB) and confirm
adequate treatment would be a major advance. The utility of interferon gamma assays …

[HTML][HTML] CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7. 7

M Ruhwald, M Bjerregaard-Andersen, P Rabna… - Microbes and …, 2007 - Elsevier
IFN-γ responses to Mycobacterium tuberculosis specific antigens are used as in vitro
diagnostic tests for tuberculosis infection. The tests are sensitive and specific for latent and …

Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits

CE Whyte, K Singh, OT Burton, M Aloulou… - Journal of Experimental …, 2022 - rupress.org
Interleukin 2 (IL-2) is a key homeostatic cytokine, with therapeutic applications in both
immunogenic and tolerogenic immune modulation. Clinical use has been hampered by …

Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10

M Ruhwald, J Petersen, K Kofoed, H Nakaoka… - PloS one, 2008 - journals.plos.org
Background There is a need for simple tools such as the M. tuberculosis specific IFN-γ
release assays (IGRA) to improve diagnosis of M. tuberculosis-infection in children. The aim …

Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?

D Goletti, A Raja, B Syed Ahamed Kabeer… - PloS one, 2010 - journals.plos.org
Background The suboptimal sensitivity of Interferon (IFN)-γ-based in-vitro assays, especially
in immunocompromised individuals, emphasizes the need for alternative markers for …

Changes in serum cytokine levels in active tuberculosis with treatment

F Deveci, HH Akbulut, T Turgut… - Mediators of …, 2005 - Wiley Online Library
It has been reported that IFN‐γ, TNF‐α, and IL‐12 stimulate, and that IL‐10, TGF‐β, and IL‐4
suppress the protective immune response against tuberculosis. We aim to evaluate changes …

Immunity to TB and targets for immunotherapy

M Gonzalez-Juarrero - Immunotherapy, 2012 - Taylor & Francis
For centuries the treatment of TB has presented an enormous challenge to global health. In
the 20th century, the treatment of TB patients with long-term multidrug therapy gave hope …

Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis

E Peresi, SMUR Silva, SA Calvi… - Jornal Brasileiro de …, 2008 - SciELO Brasil
Objective: To evaluate the pattern of pro-inflammatory cytokines, anti-inflammatory cytokines
and the acute phase response (APR) as markers of the response to treatment of pulmonary …

The role of exosomes in pancreatic cancer microenvironment

A Friedman, W Hao - Bulletin of mathematical biology, 2018 - Springer
Exosomes are nanovesicles shed by cells as a means of communication with other cells.
Exosomes contain mRNAs, microRNAs (miRs) and functional proteins. In the present paper …

IP-10 detection in urine is associated with lung diseases

A Cannas, L Calvo, T Chiacchio, G Cuzzi… - BMC infectious …, 2010 - Springer
Background blood cytokines and chemokines have been proposed as biomarkers for
tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal …